Glucuronidase: Difference between revisions

From Proteopedia
Jump to navigationJump to search
New page: ==β-Glucuronidase== <StructureSection load='3hn3' size='340' side='right' caption='Ribbon diagram of human β-glucuronidase' scene=''> This tutorial illustrates the quaternary st...
 
Michal Harel (talk | contribs)
No edit summary
 
(20 intermediate revisions by 3 users not shown)
Line 1: Line 1:
==&beta;-Glucuronidase==
<StructureSection load='3vnz' size='340' side='right' caption='β-glucuronidase complex with glucouronic acid, glycerol and PO4 ion (PDB code [[3vnz]]).' scene=''>
<StructureSection load='3hn3' size='340' side='right' caption='Ribbon diagram of human &beta;-glucuronidase' scene=''>


This tutorial illustrates the quaternary structures of the human and ''E. coli'' &beta;-glucuronidase enzyme.
This tutorial illustrates the quaternary structures of the human and ''E. coli'' &beta;-glucuronidase enzyme.


 
__TOC__


== Function ==
== Function ==
&beta;-glucuronidase is a ubiquitous enzyme that catalyzes the hydrolysis of a glucuronide moiety from a variety of substrates.  This enzyme is present throughout biological systems, including bacteria up through humans.
'''&beta;-glucuronidase''' is a ubiquitous enzyme that catalyzes the hydrolysis of a glucuronide moiety from a variety of substrates.  This enzyme is present throughout biological systems, including bacteria up through humans<ref>PMID:8599764</ref>.  '''α-glucuronidase''' catalyzes the conversion of  α-D-glucuronoside to alcohol and D-glucuronate<ref>PMID:12169619</ref>.


== Relevance ==
== Relevance ==
Deficiencies in the human form of &beta;-glucuronidase (<scene name='59/596447/Human_bglucuronidase/1'>overall structure</scene>) is associated with a disease known as Sly Syndrome (AKA Mucopolysaccharidosis VII -- MPS VII).  This disease is characterized by mental retardation, short stature, macrocephaly, and enlarged joints.  As is commonly seen with genetic disorders, patients with this disease present a spectrum of symptom severity, but the disease is always ultimately fatal.
The ''E. coli'' form of &beta;-glucuronidase (<scene name='59/596447/E_coli_b-glucuronidase/1'>overall structure</scene>, PDB ID [[3lpf]]<ref>DOI:10.2210/pdb3lpf/pdb</ref>) is associated with the side effects seen with administration of the cancer chemotherapy drug CPT-11.  This drug gets converted to SN38, a topoisomerase inhibitor, by the liver.  The body adds a glucuronide group to this molecule (now SN38-G) to mark it for elimination, which partially occurs through the intestine.  Once in the intestine, bacterial &beta;-glucuronidase cleaves the glucuronide from the SN38-G, releasing the SN38 into the intestinal lumen.  The released SN38 prevents cell division, compromising the epithelial lining of the intestines, a painful and dangerous side-effect of CPT-11 administration.


The ''E. coli'' form of &beta;-glucuronidase (<scene name='59/596447/E_coli_b-glucuronidase/1'>overall structure</scene>) is associated with the side effects seen with administration of the cancer chemotherapy drug CPT-11.  This drug gets converted to SN38, a topoisomerase inhibitor, by the liver.  The body adds a glucuronide group to this molecule (now SN38-G) to mark it for elimination, which partially occurs through the intestine.  Once in the intestine, bacterial &beta;-glucuronidase cleaves the glucuronide from the SN38-G, releasing the SN38 into the intestinal lumen.  The released SN38 prevents cell division, compromising the epithelial lining of the intestines, a painful and dangerous side-effect of CPT-11 administration.
Selective inhibition of bacterial &beta;-glucuronidase is desired to alleviate this side-effect of CPT-11 treatment, hopefully without inhibiting the human form of the enzyme<ref>PMID:9829738</ref>.
 
Selective inhibition of bacterial &beta;-glucuronidase is desired to alleviate this side-effect of CPT-11 treatment, hopefully without inhibiting the human form of the enzyme.


==Disease==
Deficiencies in the human form of &beta;-glucuronidase (<scene name='59/596447/Human_bglucuronidase/1'>overall structure</scene>, PDB ID [[3hn3]]<ref>DOI:10.2210/pdb3hn3/pdb</ref>) is associated with a disease known as Sly Syndrome (AKA Mucopolysaccharidosis VII -- MPS VII).  This disease is characterized by mental retardation, short stature, macrocephaly, and enlarged joints.  As is commonly seen with genetic disorders, patients with this disease present a spectrum of symptom severity, but the disease is always ultimately fatal.


== Structural highlights ==
== Structural highlights ==
Line 22: Line 21:
The structure of the enzyme contains both &alpha;-helix (blue) and &beta;-sheet (yellow) forms of <scene name='59/596447/E_coli_b-glucuronidase3/1'>secondary structure</scene>, with the &beta;-sheets arranged in &beta;-barrels in an immunoglobulin-like fold.   
The structure of the enzyme contains both &alpha;-helix (blue) and &beta;-sheet (yellow) forms of <scene name='59/596447/E_coli_b-glucuronidase3/1'>secondary structure</scene>, with the &beta;-sheets arranged in &beta;-barrels in an immunoglobulin-like fold.   


The <scene name='59/596476/Cv/3'>catalytic pocket</scene> of BGUS contains <scene name='59/596476/Cv/4'>two catalytic Glu residues</scene><ref>PMID:22367201</ref>.


== 3D Structures of glucuronidase ==
[[Glucuronidase 3D structures]]


</StructureSection>
</StructureSection>
== References ==
== References ==
<references/>
<references/>
<ref>DOI:10.2210/pdb3hn3/pdb</ref>
<ref>DOI:10.2210/pdb3lpf/pdb</ref>
[[Category:Topic Page]]

Latest revision as of 07:19, 13 July 2025

β-glucuronidase complex with glucouronic acid, glycerol and PO4 ion (PDB code 3vnz).

Drag the structure with the mouse to rotate

References

[1] [2]

Proteopedia Page Contributors and Editors (what is this?)

Kimberly Lane, Michal Harel, Alexander Berchansky